HomeCompareEWOOF vs ORCC

EWOOF vs ORCC: Dividend Comparison 2026

EWOOF yields 288.31% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EWOOF wins by $1160.76M in total portfolio value
10 years
EWOOF
EWOOF
● Live price
288.31%
Share price
$0.69
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1160.78M
Annual income
$689,991,475.77
Full EWOOF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — EWOOF vs ORCC

📍 EWOOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEWOOFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EWOOF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EWOOF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EWOOF
Annual income on $10K today (after 15% tax)
$24,506.27/yr
After 10yr DRIP, annual income (after tax)
$586,492,754.40/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, EWOOF beats the other by $586,492,753.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EWOOF + ORCC for your $10,000?

EWOOF: 50%ORCC: 50%
100% ORCC50/50100% EWOOF
Portfolio after 10yr
$580.40M
Annual income
$344,995,738.40/yr
Blended yield
59.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

EWOOF
No analyst data
Altman Z
-5.5
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EWOOF buys
0
ORCC buys
0
No recent congressional trades found for EWOOF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEWOOFORCC
Forward yield288.31%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$1160.78M$21.4K
Annual income after 10y$689,991,475.77$1.04
Total dividends collected$1112.94M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: EWOOF vs ORCC ($10,000, DRIP)

YearEWOOF PortfolioEWOOF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$39,531$28,830.91$11,190$489.61+$28.3KEWOOF
2$148,813$106,515.13$12,229$256.01+$136.6KEWOOF
3$533,972$374,741.85$13,216$130.74+$520.8KEWOOF
4$1,828,032$1,256,682.11$14,207$66.02+$1.81MEWOOF
5$5,976,744$4,020,749.48$15,234$33.17+$5.96MEWOOF
6$18,680,933$12,285,817.42$16,317$16.62+$18.66MEWOOF
7$55,877,008$35,888,409.04$17,468$8.32+$55.86MEWOOF
8$160,112,435$100,324,036.73$18,695$4.16+$160.09MEWOOF
9$439,986,573$268,666,267.61$20,006$2.08+$439.97MEWOOF
10$1,160,777,109$689,991,475.77$21,407$1.04+$1160.76MEWOOF

EWOOF vs ORCC: Complete Analysis 2026

EWOOFStock

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.

Full EWOOF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this EWOOF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EWOOF vs SCHDEWOOF vs JEPIEWOOF vs OEWOOF vs KOEWOOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.